Ozon Pharmaceuticals increased its portfolio of registration certificates to 535

Ozon Pharmaceuticals received 31 registration certificates in 2024. They cover both prescription and over-the-counter segments in various pharmacological groups. Since 2021, the company's portfolio of registration certificates has grown by 20% from 445 to 535. Currently, 246 drugs are at various stages of development and registration, which will ensure high dynamics of new registrations in the future.